146 related articles for article (PubMed ID: 12956401)
1. Arteriosclerosis in rat aortic allografts: dynamics of cell growth, apoptosis and expression of extracellular matrix proteins.
Religa P; Bojakowski K; Gaciong Z; Thyberg J; Hedin U
Mol Cell Biochem; 2003 Jul; 249(1-2):75-83. PubMed ID: 12956401
[TBL] [Abstract][Full Text] [Related]
2. Arteriosclerosis in rat aortic allografts: early changes in endothelial integrity and smooth muscle phenotype.
Bojakowski K; Religa P; Bojakowska M; Hedin U; Gaciong Z; Thyberg J
Transplantation; 2000 Jul; 70(1):65-72. PubMed ID: 10919577
[TBL] [Abstract][Full Text] [Related]
3. Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosis.
Religa P; Bojakowski K; Bojakowska M; Gaciong Z; Thyberg J; Hedin U
Cardiovasc Res; 2005 Feb; 65(2):535-45. PubMed ID: 15639493
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation.
Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeuchi K; Takeyoshi I; Morishita Y; Kobayashi E
Transplantation; 2004 Jun; 77(11):1661-7. PubMed ID: 15201664
[TBL] [Abstract][Full Text] [Related]
5. Medial smooth muscle cell loss in arterial allografts occurs by cytolytic cell induced apoptosis.
Hirsch GM; Kearsey J; Burt T; Karnovsky MJ; Lee T
Eur J Cardiothorac Surg; 1998 Jul; 14(1):89-96; discussion 96-7. PubMed ID: 9726621
[TBL] [Abstract][Full Text] [Related]
6. The origin of neointimal smooth muscle cells in transplant arteriosclerosis from recipient bone-marrow cells in rat aortic allograft.
Song Z; Li W; Zheng Q; Shang D; Shu X; Guan S
J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):303-6. PubMed ID: 17641848
[TBL] [Abstract][Full Text] [Related]
7. N-octanoyl Dopamine Attenuates the Development of Transplant Vasculopathy in Rat Aortic Allografts Via Smooth Muscle Cell Protective Mechanisms.
Wedel J; Hottenrott MC; Bulthuis M; Huitema S; Yard BA; Hillebrands JL
Transplantation; 2016 Jan; 100(1):80-90. PubMed ID: 26674731
[TBL] [Abstract][Full Text] [Related]
8. Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency.
Onuta G; van Ark J; Rienstra H; Boer MW; Klatter FA; Bruggeman CA; Zeebregts CJ; Rozing J; Hillebrands JL
Atherosclerosis; 2010 Apr; 209(2):393-402. PubMed ID: 19913790
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated heme oxygenase transfer inhibits graft arteriosclerosis in rat aortic transplants.
Du D; Chang S; Chen B; Zhou H; Chen ZK
Transplant Proc; 2007 Dec; 39(10):3446-8. PubMed ID: 18089403
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated anti-sense extracellular signal-regulated kinase 2 gene therapy inhibits activation of vascular smooth muscle cells and angiogenesis, and ameliorates transplant arteriosclerosis.
Zhao B; Li X; Dai X; Gong N
Transplant Proc; 2013 Mar; 45(2):639-42. PubMed ID: 23498803
[TBL] [Abstract][Full Text] [Related]
11. Smooth-muscle progenitor cells of bone marrow origin contribute to the development of neointimal thickenings in rat aortic allografts and injured rat carotid arteries.
Religa P; Bojakowski K; Maksymowicz M; Bojakowska M; Sirsjö A; Gaciong Z; Olszewski W; Hedin U; Thyberg J
Transplantation; 2002 Nov; 74(9):1310-5. PubMed ID: 12451271
[TBL] [Abstract][Full Text] [Related]
12. Perigraft adventitia and intima remodeling after synthetic patch implantation in sheep carotid artery: role of apoptosis and proliferation.
Huang P; Hawthorne WJ; Ao P; Angeli GL; Medbury HJ; Fletcher JP
J Vasc Surg; 2002 Aug; 36(2):371-8. PubMed ID: 12170220
[TBL] [Abstract][Full Text] [Related]
13. Exposure of vascular allografts to insulin-like growth factor-I (IGF-I) increases vascular expression of IGF-I ligand and receptor protein and accelerates arteriosclerosis in rats.
Motomura N; Lou H; Orskov H; Ramwell PW; Foegh ML
Transplantation; 1998 Apr; 65(8):1024-30. PubMed ID: 9583860
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Inhibition of Vanin Activity Attenuates Transplant Vasculopathy in Rat Aortic Allografts.
Wedel J; Jansen PA; Botman PN; Rutjes FP; Schalkwijk J; Hillebrands JL
Transplantation; 2016 Aug; 100(8):1656-66. PubMed ID: 27014792
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix composition and cellular mechanisms of transplant vasculopathy in rat aortic allografts.
Religa P; Bojakowski K; Bojakowska M; Gaciong Z; Thyberg J; Hedin U
Transplant Proc; 2002 Mar; 34(2):687-8. PubMed ID: 12009665
[No Abstract] [Full Text] [Related]
16. Transplant arteriosclerosis in a rat aortic model.
Isik FF; McDonald TO; Ferguson M; Yamanaka E; Gordon D
Am J Pathol; 1992 Nov; 141(5):1139-49. PubMed ID: 1443048
[TBL] [Abstract][Full Text] [Related]
17. Effect of sarpogrelate hydrochloride, a 5-hydroxytryptamine2 receptor antagonist, on allograft arteriosclerosis after aortic transplantation in rats.
Watada S; Harada H; Matsubara K; Obara H; Matsumoto K; Ando N; Kitagawa Y
Transpl Immunol; 2013 Dec; 29(1-4):162-6. PubMed ID: 23851153
[TBL] [Abstract][Full Text] [Related]
18. Bax and apoptosis in acute and chronic rejection of rat cardiac allografts.
Dong C; Granville DJ; Tuffnel CE; Kenyon J; English D; Wilson JE; McManus BM
Lab Invest; 1999 Dec; 79(12):1643-53. PubMed ID: 10616213
[TBL] [Abstract][Full Text] [Related]
19. Morphology and immunohistochemistry of rat aortic grafts.
Rossmann P; Lácha J; Lodererová A
Folia Microbiol (Praha); 1999; 44(3):339-53. PubMed ID: 10664891
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of chronic rejection of aortic allografts by dietary glycine.
Yin M; Rusyn I; Schoonhoven R; Graves LM; Rusyn EV; Li X; Li F; Cox AD; Harding TW; Bunzendahl H; Swenberg JA; Thurman RG
Transplantation; 2000 Mar; 69(5):773-80. PubMed ID: 10755525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
